Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation.
In a prospective study of human leptospirosis, thrombocytopenia was demonstrated in 54% of 24 cases. The only additional laboratory evidence suggestive of disseminated intravascular coagulation lay in a mild elevation of fibrinogen degradation products, but this occurred with equal frequency in nonthrombocytopenic patients. There is therefore no causal relationship between disseminated intravascular coagulation and the thrombocytopenia of human leptospirosis.
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000469:parasitology*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007728:Kupffer Cells / Q000378:metabolism; D007922:Leptospirosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011446:Prospective Studies; D013921:Thrombocytopenia / Q000209:etiology / Q000469:parasitology*
D005340:Fibrinogen; D000410:Alanine Transaminase